LGP Flower THC 25 Bush Lantern Medical Cannabis Flower

LGP Flower THC 25 Bush Lantern medical cannabis flower

Bush Lantern is Little Green Pharma’s flagship cultivar, grown in-house to anchor the brand’s own flower range with a strong, dependable 25 percent THC profile. Developed as the signature strain for prescribed patients across the country, Bush Lantern has built its reputation on consistent potency, a balanced earthy aroma, and dense, well-structured buds that reflect close oversight throughout cultivation.

As the flagship product, it receives the same attention to detail that defines Little Green Pharma’s broader quality standards, while being produced at a scale that supports steady national availability.

This combination of strength and reliability matters for patients who depend on a stable flower option as part of an ongoing treatment plan. Little Green Pharma manages every stage of Bush Lantern’s cultivation, drying, and curing in-house, allowing tighter quality control than is typically possible with third-party sourced flower. For many patients, knowing exactly which company stands behind their flower, from seed to seal, is an important part of choosing a flagship product.

Little Green Pharma positions Bush Lantern as a core, always-available strain within its own brand range, distinct from limited or seasonal releases from partner cultivators. Patients who rely on Bush Lantern for regular treatment can generally expect consistent access to new batches as part of their ongoing prescription.

THC percentage

Each batch of Bush Lantern is tested by an independent laboratory, and the certificate of analysis reports total THC content specific to that harvest, targeting the strain’s signature 25 percent THC range. Patients should always refer to the batch-specific COA rather than the general percentage in the product name, since potency can vary slightly between harvests even within a well-established cultivar.

Maintaining standardised in-house growing conditions helps Little Green Pharma keep THC output consistent for Bush Lantern across batches, which is part of what has made it a dependable flagship choice for patients managing ongoing conditions.

Patients managing their dosage closely should keep their COA on file and compare it against previous batches they have used, as this is the most accurate way to track potency changes and adjust dosing in consultation with their prescriber.

Therapeutic Goods Administration cannabis guidance

CBD percentage

Bush Lantern is primarily cultivated as a THC-dominant cultivar, and its CBD content is generally modest and reported on each batch’s certificate of analysis. Even at lower concentrations, CBD contributes to the overall cannabinoid profile and may play a role in the entourage effect alongside THC and the cultivar’s terpenes.

Little Green Pharma’s quality team tests for CBD alongside THC on every batch to ensure the full cannabinoid picture is available to prescribing doctors and patients. This transparency allows patients to make informed decisions about whether this particular cannabinoid ratio suits their treatment goals.

Patients who require a more balanced or CBD-forward profile should discuss alternative cultivars in the Little Green Pharma range with their prescriber, as Bush Lantern is best suited to those seeking a predominantly THC-driven effect.

Terpene profile

Bush Lantern carries a balanced, earthy terpene profile with subtle herbal and woody undertones, a character that has remained consistent across its time as Little Green Pharma’s flagship strain. Terpenes are responsible for both the aroma and much of the nuanced sensory experience of cannabis, and the in-house cultivation team applies standardised drying and curing protocols to maintain this profile reliably across production runs.

Controlled drying and curing remain central to terpene retention, since heat and rushed processing can degrade these compounds quickly regardless of cultivation scale. The team manages humidity and temperature carefully throughout this stage to protect the aromatic profile patients have come to associate with Bush Lantern.

Each batch’s terpene report, where available, is included alongside the cannabinoid COA so patients can see exactly which terpenes are present in their specific harvest, supporting a more informed approach to ongoing treatment.

NCBI research on cannabis terpenes

Cultivar lineage

Bush Lantern has been selected and refined as Little Green Pharma’s flagship genetic line for its dependable structural qualities, including dense bud formation and good trichome coverage, alongside its recognisable earthy terpene character. Its lineage reflects the company’s focus on a cultivar that performs reliably at scale without sacrificing the quality patients expect from the brand.

Genetic stability is essential for a flagship strain produced consistently across many batches, since it allows the cultivation team to reproduce a stable phenotype rather than facing the variability that can occur with less established genetics. This consistency is a core part of why Bush Lantern has become the brand’s signature offering.

Patients who have used Bush Lantern previously can have confidence that each new batch is grown from the same well-maintained genetic stock that underpins its position as the flagship LGP strain.

Batch testing

Every batch of Bush Lantern undergoes independent laboratory testing prior to release, covering cannabinoid potency, terpene content where applicable, and screening for contaminants such as microbials, heavy metals, and pesticide residues. This testing regime is a core part of Little Green Pharma’s quality assurance process and applies equally to its flagship strain as to any other product in the range.

Results are documented in a certificate of analysis that is batch-specific, meaning the figures correspond exactly to the jar a patient receives rather than an average across multiple harvests. This level of traceability matters in a therapeutic context, where dosing accuracy directly affects patient outcomes.

Patients are encouraged to request or review their batch’s COA and raise any questions about testing results with their prescribing doctor or pharmacist before adjusting their usual dosing routine.

Moisture content

Moisture content is carefully monitored throughout drying and curing to ensure Bush Lantern arrives at an optimal level for both safe storage and consistent inhalation performance. Flower that is too moist is prone to mould risk and uneven burning, while flower that is too dry can lose terpene content and become harsh.

Little Green Pharma applies standardised drying schedules across Bush Lantern production to ensure moisture content remains consistent from batch to batch, supporting the predictable inhalation experience patients expect from a flagship strain.

Proper storage after delivery, in a cool, dark, airtight environment, helps maintain the moisture balance achieved during processing, and patients are encouraged to keep flower in its original sealed packaging until ready for use.

Trim quality
Bush Lantern undergoes a quality-controlled trimming process designed to maintain consistent bud presentation across every production run. Little Green Pharma applies strict in-house quality benchmarks to ensure excess leaf material is removed without compromising trichome coverage, supporting both visual appeal and therapeutic value.

This results in buds that are reliably well presented and structurally consistent from batch to batch, which has contributed to patient confidence in Bush Lantern as the brand’s flagship flower.

Maintaining this trim standard also supports consistent airflow during curing, helping protect the moisture balance and terpene retention discussed above across every batch.

Packaging freshness seal

Bush Lantern is packaged in airtight, light-protective containers fitted with a tamper-evident freshness seal, designed to lock in aroma and protect against light degradation and moisture loss during transit and storage. This packaging standard is applied consistently across all Little Green Pharma flower, including its flagship strain.

The seal also provides an additional layer of assurance for patients, confirming the product has not been opened or accessed between leaving the dispensing pharmacy and arriving at the patient’s door.

Patients should inspect the seal upon arrival and retain original packaging for storage to preserve freshness for as long as possible after opening.

Shipping, insurance, and delivery assurance

All orders are covered by insured freight, meaning the value of the shipment is protected in the event of loss or damage during transit, giving patients confidence that their prescribed treatment is financially safeguarded from dispatch to doorstep. Given the prescription nature of this product, deliveries require a signature on delivery, ensuring the package is received directly by the patient or an authorised recipient.

Before any order leaves the dispensing facility, it passes through pre-shipment quality checks, which confirm that packaging seals are intact, labelling is correct, and the product matches the prescription on file. This step exists specifically to catch any issues before they reach the patient.

In the rare event that an issue does occur, a clear damage claim process is available. Patients should photograph the affected packaging and product immediately upon receipt and contact customer support within the stated claim window so the matter can be assessed and resolved promptly.

To explore further cultivars from across the Little Green Pharma range, browse the full dried flower collection at https://littlegreenpharma.shop/product-category/dried-flower-inhalation/

Frequently Asked Questions